Cooper Companies (NASDAQ:COO) Shares Gap Up After Earnings Beat

The Cooper Companies, Inc. (NASDAQ:COO)’s share price gapped up prior to trading on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $77.03, but opened at $89.66. Cooper Companies shares last traded at $83.2810, with a volume of 1,556,324 shares traded.

The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS.

Cooper Companies declared that its board has initiated a stock buyback program on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on COO shares. Weiss Ratings restated a “hold (c-)” rating on shares of Cooper Companies in a research report on Monday. Robert W. Baird boosted their target price on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, August 28th. Barclays initiated coverage on Cooper Companies in a research note on Monday, October 13th. They set an “overweight” rating and a $85.00 target price for the company. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $100.00 price target (up previously from $94.00) on shares of Cooper Companies in a report on Friday. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $88.62.

Insider Activity

In other news, Director Lawrence Erik Kurzius acquired 2,000 shares of the firm’s stock in a transaction dated Monday, September 29th. The stock was bought at an average price of $68.39 per share, with a total value of $136,780.00. Following the transaction, the director directly owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.98% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors have recently bought and sold shares of COO. Bell Investment Advisors Inc boosted its stake in shares of Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the period. Zions Bancorporation National Association UT bought a new stake in Cooper Companies during the first quarter worth about $33,000. J.Safra Asset Management Corp grew its stake in Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after buying an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in Cooper Companies in the 2nd quarter valued at about $36,000. Finally, GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies in the 1st quarter valued at approximately $40,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The company has a market cap of $16.52 billion, a P/E ratio of 40.78, a P/E/G ratio of 1.87 and a beta of 1.05. The stock’s fifty day moving average price is $72.01 and its two-hundred day moving average price is $71.74.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.